ATE316797T1 - Verfahren zur herstellung multivalenter impfstoffe - Google Patents
Verfahren zur herstellung multivalenter impfstoffeInfo
- Publication number
- ATE316797T1 ATE316797T1 AT97909341T AT97909341T ATE316797T1 AT E316797 T1 ATE316797 T1 AT E316797T1 AT 97909341 T AT97909341 T AT 97909341T AT 97909341 T AT97909341 T AT 97909341T AT E316797 T1 ATE316797 T1 AT E316797T1
- Authority
- AT
- Austria
- Prior art keywords
- vaccine
- components
- component
- composition
- toxoid
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 229940031348 multivalent vaccine Drugs 0.000 title 1
- 229960005486 vaccine Drugs 0.000 abstract 4
- 229960003983 diphtheria toxoid Drugs 0.000 abstract 3
- 229960000814 tetanus toxoid Drugs 0.000 abstract 3
- 241000991587 Enterovirus C Species 0.000 abstract 1
- 241000606790 Haemophilus Species 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 208000002672 hepatitis B Diseases 0.000 abstract 1
- 230000005847 immunogenicity Effects 0.000 abstract 1
- 229940066827 pertussis vaccine Drugs 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
- A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP1997/005378 WO1999013906A1 (en) | 1997-09-15 | 1997-09-15 | Multivalent vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE316797T1 true ATE316797T1 (de) | 2006-02-15 |
Family
ID=8166750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97909341T ATE316797T1 (de) | 1997-09-15 | 1997-09-15 | Verfahren zur herstellung multivalenter impfstoffe |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1028750B1 (de) |
| AT (1) | ATE316797T1 (de) |
| AU (1) | AU4707097A (de) |
| BR (1) | BR9714980A (de) |
| CA (1) | CA2303105A1 (de) |
| DE (1) | DE69735191T2 (de) |
| DK (1) | DK1028750T3 (de) |
| ES (1) | ES2257769T3 (de) |
| PT (1) | PT1028750E (de) |
| WO (1) | WO1999013906A1 (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1004314A1 (de) * | 1998-11-26 | 2000-05-31 | Pasteur Merieux MSD | T.d.Polio Impstoff für einer primovakzinierter oder empfindlicher Population |
| KR100374813B1 (ko) * | 2000-04-07 | 2003-03-03 | 녹십자백신 주식회사 | 디프테리아, 파상풍 톡소이드, 정제백일해 및비형간염표면항원을 포함한 4가 혼합백신 및 그 제조 방법 |
| GB0108364D0 (en) | 2001-04-03 | 2001-05-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
| SK288007B6 (sk) * | 2000-06-29 | 2012-10-02 | Glaxosmithkline Biologicals S. A. | Multivalent vaccine composition, process for its producing, and its use |
| KR100401423B1 (ko) * | 2001-01-10 | 2003-10-17 | 주식회사 엘지생명과학 | 혼합 백신의 제조 방법 |
| LT1556477T (lt) | 2002-11-01 | 2017-10-25 | Glaxosmithkline Biologicals S.A. | Džiovinimo būdas |
| GB0313916D0 (en) | 2003-06-16 | 2003-07-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
| GB0505518D0 (en) * | 2005-03-17 | 2005-04-27 | Chiron Srl | Combination vaccines with whole cell pertussis antigen |
| CA2612980C (en) | 2005-06-27 | 2019-01-15 | Glaxosmithkline Biologicals S.A. | Immunogenic composition comprising a haemophilus influenzae type b saccharide conjugate |
| US8124397B2 (en) | 2005-08-08 | 2012-02-28 | Oregon Health & Science University | Inactivating pathogens with oxidizing agents for vaccine production |
| GB0616306D0 (en) * | 2006-08-16 | 2006-09-27 | Novartis Ag | Vaccines |
| CA2662064A1 (en) | 2006-09-07 | 2008-03-13 | Glaxosmithkline Biologicals S.A. | Method of producing a combination polivirus vaccine |
| PE20100366A1 (es) | 2008-10-24 | 2010-05-21 | Panacea Biotec Ltd | Novedosas composiciones de vacuna con tos ferina acelular asi como el metodo para su elaboracion |
| GB0822633D0 (en) * | 2008-12-11 | 2009-01-21 | Novartis Ag | Formulation |
| RU2705163C2 (ru) | 2011-01-05 | 2019-11-05 | Бхарат Байотек Интернэшнл Лимитед | Комбинированная семивалентная вакцина |
| FR2985663B1 (fr) * | 2012-01-17 | 2015-03-27 | Sanofi Pasteur | Procede de formulation d'un vaccin contenant au moins deux antigenes susceptibles de s'adsorber sur de l'oxy hydroxyde d'aluminium |
| BR112015008040A2 (pt) * | 2012-10-12 | 2017-07-04 | Glaxosmithkline Biologicals Sa | composição de vacina, vacina de combinação, e, processos para preparar um componente ap e para a fabricação de uma composição de vacina |
| US9849066B2 (en) | 2013-04-24 | 2017-12-26 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
| CN105646726A (zh) * | 2016-02-03 | 2016-06-08 | 成都康华生物制品有限公司 | 一种b型流感嗜血杆菌荚膜多糖的制备方法及联合疫苗 |
| UA128204C2 (uk) | 2017-07-18 | 2024-05-08 | Сірем Інстітьют Оф Індіа Пвт Лтд. | Імуногенна композиція з покращеною стабільністю, підвищеною імуногенністю та зниженою реактогенністю і спосіб її виготовлення |
| JOP20190242A1 (ar) | 2018-10-12 | 2020-04-12 | Serum Institute Of India Pvt Ltd | تركيبة لقاح توليفي تشمل فيروس شلل الأطفال ذو جرعة مخفّضة خاملة التنشيط وطريقة لتحضيرها |
| US11433129B2 (en) | 2019-05-20 | 2022-09-06 | Soligenix, Inc. | Compositions and methods of manufacturing trivalent filovirus vaccines |
| WO2022224966A1 (ja) | 2021-04-20 | 2022-10-27 | Ｋｍバイオロジクス株式会社 | ６種混合液状ワクチン組成物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0835663T3 (da) * | 1992-05-23 | 2010-02-01 | Glaxosmithkline Biolog Sa | Kombinerede vacciner omfattende Hepatitis B overfladeantigen og andre antigener |
| DE69736709T2 (de) * | 1996-07-02 | 2007-10-04 | Sanofi Pasteur Ltd., Toronto | Vielwertige dtp-polio-impfstoffe |
-
1997
- 1997-09-15 AT AT97909341T patent/ATE316797T1/de active
- 1997-09-15 WO PCT/EP1997/005378 patent/WO1999013906A1/en active IP Right Grant
- 1997-09-15 BR BR9714980-2A patent/BR9714980A/pt not_active Application Discontinuation
- 1997-09-15 PT PT97909341T patent/PT1028750E/pt unknown
- 1997-09-15 AU AU47070/97A patent/AU4707097A/en not_active Abandoned
- 1997-09-15 DE DE69735191T patent/DE69735191T2/de not_active Expired - Lifetime
- 1997-09-15 CA CA002303105A patent/CA2303105A1/en not_active Abandoned
- 1997-09-15 DK DK97909341T patent/DK1028750T3/da active
- 1997-09-15 EP EP97909341A patent/EP1028750B1/de not_active Expired - Lifetime
- 1997-09-15 ES ES97909341T patent/ES2257769T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1028750B1 (de) | 2006-02-01 |
| PT1028750E (pt) | 2006-05-31 |
| EP1028750A1 (de) | 2000-08-23 |
| DK1028750T3 (da) | 2006-05-22 |
| ES2257769T3 (es) | 2006-08-01 |
| AU4707097A (en) | 1999-04-05 |
| CA2303105A1 (en) | 1999-03-25 |
| DE69735191T2 (de) | 2006-10-05 |
| BR9714980A (pt) | 2001-11-06 |
| WO1999013906A1 (en) | 1999-03-25 |
| DE69735191D1 (de) | 2006-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE316797T1 (de) | Verfahren zur herstellung multivalenter impfstoffe | |
| DE69736709D1 (de) | Vielwertige dtp-polio-impfstoffe | |
| HU1000593D0 (en) | Vaccine compositions | |
| LU91658I2 (fr) | Vaccin combiné diphtérique, tétanique, coquelucheux, hépatite B, poliomyélitique et Haemophilus influenzae type B conjugué (INFANRIX HEXA®) | |
| RU2009105117A (ru) | Композиции, включающие антигены neisseria meningitidis из серогрупп в и с, и дополнительный антиген | |
| SI1835939T1 (sl) | Cepljenje na osnovi meningokoknih konjugatov | |
| CA2277141A1 (en) | Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this procedure | |
| PL1740217T3 (pl) | Szczepienie koniugatem meningokokowym | |
| UA27754C2 (uk) | Комбінована педіатрична вакцина, спосіб одночасної комбінованої вакцинації | |
| AU2001269569A1 (en) | Quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis surface antigen, and preparation method thereof | |
| WO2000051633A3 (en) | MULTI-COMPONENT VACCINE COMPRISING AT LEAST THREE ANTIGENS TO PROTECT AGAINST DISEASE CAUSED BY $i(HAEMOPHILUS INFLUENZAE) | |
| DK1200122T3 (da) | Multikomponentvaccine til beskyttelse mod sygdom, som er forårsaget af Haemophilus influenzae og Moraxella catarrhalis | |
| GB9611501D0 (en) | Vaccine compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1028750 Country of ref document: EP |